Loading…
A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity
Histological classification is essential in the clinical management of immunoglobulin A nephropathy (IgAN). However, there are limitations in predicting the prognosis of IgAN based on histological information alone, which suggests the need for better prognostic models. Therefore, we defined a progno...
Saved in:
Published in: | Clinical and experimental nephrology 2019-01, Vol.23 (1), p.16-25 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3 |
container_end_page | 25 |
container_issue | 1 |
container_start_page | 16 |
container_title | Clinical and experimental nephrology |
container_volume | 23 |
creator | Okonogi, Hideo Kawamura, Tetsuya Joh, Kensuke Koike, Kentaro Miyazaki, Yoichi Ogura, Makoto Tsuboi, Nobuo Hirano, Keita Matsushima, Masato Yokoo, Takashi Horikoshi, Satoshi Suzuki, Yusuke Yasuda, Takashi Shirai, Sayuri Shibata, Takanori Hattori, Motoshi Akioka, Yuko Katafuchi, Ritsuko Hashiguchi, Akinori Hisano, Satoshi Shimizu, Akira Kimura, Kenjiro Maruyama, Shoichi Matsuo, Seiichi Tomino, Yasuhiko |
description | Histological classification is essential in the clinical management of immunoglobulin A nephropathy (IgAN). However, there are limitations in predicting the prognosis of IgAN based on histological information alone, which suggests the need for better prognostic models. Therefore, we defined a prognostic model by combining the grade of clinical severity with the histological grading system by the following processes. We included 270 patients and explored the clinical variables associated with progression to end-stage renal disease (ESRD). Then, we created a predictive clinical grading system and defined the risk grades for dialysis induction by a combination of the clinical grade (CG) and the histological grade (HG). A logistic regression analysis revealed that the 24-h urinary protein excretion (UPE) and the estimated glomerular filtration rate (eGFR) were significant independent variables. We selected UPE of 0.5 g/day and eGFR of 60 ml/min/1.73 m
2
as the threshold values for the classification of CG. The risk of progression to ESRD of patients with CG II and III was significantly higher than that of patients with CG I. The patients were then re-classified into nine compartments based on the combination of CG and HG. Furthermore, the nine compartments were grouped into four risk groups. The risk of ESRD in the moderate, high, and super-high-risk groups was significantly higher than that in the low-risk group. Herein, we are giving a detailed description of our grading system for IgA nephropathy that predicted the risk of dialysis based on the combination of CG and HG. |
doi_str_mv | 10.1007/s10157-018-1657-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6344391</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2125575413</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3</originalsourceid><addsrcrecordid>eNp1kctu1TAQhiMEoqXwAGyQJTZsAp7Yjk82SEcVl0qV2MDacpw5iUtiB9uplHfpw-KcU8pFYmOPx9_8nvFfFC-BvgVK5bsIFIQsKexKqLfgUXEOnMlSyqZ5nGPGqxKkgLPiWYw3lNJdI5qnxRmjrJYM5Hlxtyd90J11PYlrTDiRNOhE5oCdNSnmE5Jg43fiD6SzelyjjcS6bjHJepcjctXvicN5CH7WaVhJXi26XNrqiB3J0KZh_NRap49FWeqYGq2zRo9Eu44MNiY_-v6YiHiLwab1efHkoMeIL-73i-Lbxw9fLz-X118-XV3ur0sjeJNK0-ZxuWFCIJW0rQGQcTAU5Y62kkotQDJKhaihaWWF2MmupgZZ_rwGecsuivcn3XlpJ-xMbj_oUc3BTjqsymur_r5xdlC9v1U145w1kAXe3AsE_2PBmNRko8Fx1A79ElUFVd1ALaHK6Ot_0Bu_BJfH2yghpODAMgUnygQfY8DDQzNA1ea9Onmvsvdq817RXPPqzykeKn6ZnYHqBMR85XoMv5_-v-pPHb28gg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2125575413</pqid></control><display><type>article</type><title>A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity</title><source>Springer Nature</source><creator>Okonogi, Hideo ; Kawamura, Tetsuya ; Joh, Kensuke ; Koike, Kentaro ; Miyazaki, Yoichi ; Ogura, Makoto ; Tsuboi, Nobuo ; Hirano, Keita ; Matsushima, Masato ; Yokoo, Takashi ; Horikoshi, Satoshi ; Suzuki, Yusuke ; Yasuda, Takashi ; Shirai, Sayuri ; Shibata, Takanori ; Hattori, Motoshi ; Akioka, Yuko ; Katafuchi, Ritsuko ; Hashiguchi, Akinori ; Hisano, Satoshi ; Shimizu, Akira ; Kimura, Kenjiro ; Maruyama, Shoichi ; Matsuo, Seiichi ; Tomino, Yasuhiko</creator><creatorcontrib>Okonogi, Hideo ; Kawamura, Tetsuya ; Joh, Kensuke ; Koike, Kentaro ; Miyazaki, Yoichi ; Ogura, Makoto ; Tsuboi, Nobuo ; Hirano, Keita ; Matsushima, Masato ; Yokoo, Takashi ; Horikoshi, Satoshi ; Suzuki, Yusuke ; Yasuda, Takashi ; Shirai, Sayuri ; Shibata, Takanori ; Hattori, Motoshi ; Akioka, Yuko ; Katafuchi, Ritsuko ; Hashiguchi, Akinori ; Hisano, Satoshi ; Shimizu, Akira ; Kimura, Kenjiro ; Maruyama, Shoichi ; Matsuo, Seiichi ; Tomino, Yasuhiko ; Special IgA Nephropathy Study Group ; for The Special IgA Nephropathy Study Group</creatorcontrib><description>Histological classification is essential in the clinical management of immunoglobulin A nephropathy (IgAN). However, there are limitations in predicting the prognosis of IgAN based on histological information alone, which suggests the need for better prognostic models. Therefore, we defined a prognostic model by combining the grade of clinical severity with the histological grading system by the following processes. We included 270 patients and explored the clinical variables associated with progression to end-stage renal disease (ESRD). Then, we created a predictive clinical grading system and defined the risk grades for dialysis induction by a combination of the clinical grade (CG) and the histological grade (HG). A logistic regression analysis revealed that the 24-h urinary protein excretion (UPE) and the estimated glomerular filtration rate (eGFR) were significant independent variables. We selected UPE of 0.5 g/day and eGFR of 60 ml/min/1.73 m
2
as the threshold values for the classification of CG. The risk of progression to ESRD of patients with CG II and III was significantly higher than that of patients with CG I. The patients were then re-classified into nine compartments based on the combination of CG and HG. Furthermore, the nine compartments were grouped into four risk groups. The risk of ESRD in the moderate, high, and super-high-risk groups was significantly higher than that in the low-risk group. Herein, we are giving a detailed description of our grading system for IgA nephropathy that predicted the risk of dialysis based on the combination of CG and HG.</description><identifier>ISSN: 1342-1751</identifier><identifier>ISSN: 1437-7799</identifier><identifier>EISSN: 1437-7799</identifier><identifier>DOI: 10.1007/s10157-018-1657-0</identifier><identifier>PMID: 30367317</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Dialysis ; Disease Progression ; End-stage renal disease ; Epidermal growth factor receptors ; Excretion ; Glomerular filtration rate ; Glomerulonephritis, IGA - diagnosis ; Glomerulonephritis, IGA - pathology ; Glomerulonephritis, IGA - therapy ; Hemodialysis ; Humans ; IgA nephropathy ; Immunoglobulin A ; Kidney diseases ; Kidney Function Tests ; Medicine ; Medicine & Public Health ; Nephrology ; Risk Assessment ; Risk groups ; Special Report ; Urology</subject><ispartof>Clinical and experimental nephrology, 2019-01, Vol.23 (1), p.16-25</ispartof><rights>The Author(s) 2018</rights><rights>Clinical and Experimental Nephrology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3</citedby><cites>FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3</cites><orcidid>0000-0002-8376-5273</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30367317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okonogi, Hideo</creatorcontrib><creatorcontrib>Kawamura, Tetsuya</creatorcontrib><creatorcontrib>Joh, Kensuke</creatorcontrib><creatorcontrib>Koike, Kentaro</creatorcontrib><creatorcontrib>Miyazaki, Yoichi</creatorcontrib><creatorcontrib>Ogura, Makoto</creatorcontrib><creatorcontrib>Tsuboi, Nobuo</creatorcontrib><creatorcontrib>Hirano, Keita</creatorcontrib><creatorcontrib>Matsushima, Masato</creatorcontrib><creatorcontrib>Yokoo, Takashi</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Suzuki, Yusuke</creatorcontrib><creatorcontrib>Yasuda, Takashi</creatorcontrib><creatorcontrib>Shirai, Sayuri</creatorcontrib><creatorcontrib>Shibata, Takanori</creatorcontrib><creatorcontrib>Hattori, Motoshi</creatorcontrib><creatorcontrib>Akioka, Yuko</creatorcontrib><creatorcontrib>Katafuchi, Ritsuko</creatorcontrib><creatorcontrib>Hashiguchi, Akinori</creatorcontrib><creatorcontrib>Hisano, Satoshi</creatorcontrib><creatorcontrib>Shimizu, Akira</creatorcontrib><creatorcontrib>Kimura, Kenjiro</creatorcontrib><creatorcontrib>Maruyama, Shoichi</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><creatorcontrib>Special IgA Nephropathy Study Group</creatorcontrib><creatorcontrib>for The Special IgA Nephropathy Study Group</creatorcontrib><title>A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity</title><title>Clinical and experimental nephrology</title><addtitle>Clin Exp Nephrol</addtitle><addtitle>Clin Exp Nephrol</addtitle><description>Histological classification is essential in the clinical management of immunoglobulin A nephropathy (IgAN). However, there are limitations in predicting the prognosis of IgAN based on histological information alone, which suggests the need for better prognostic models. Therefore, we defined a prognostic model by combining the grade of clinical severity with the histological grading system by the following processes. We included 270 patients and explored the clinical variables associated with progression to end-stage renal disease (ESRD). Then, we created a predictive clinical grading system and defined the risk grades for dialysis induction by a combination of the clinical grade (CG) and the histological grade (HG). A logistic regression analysis revealed that the 24-h urinary protein excretion (UPE) and the estimated glomerular filtration rate (eGFR) were significant independent variables. We selected UPE of 0.5 g/day and eGFR of 60 ml/min/1.73 m
2
as the threshold values for the classification of CG. The risk of progression to ESRD of patients with CG II and III was significantly higher than that of patients with CG I. The patients were then re-classified into nine compartments based on the combination of CG and HG. Furthermore, the nine compartments were grouped into four risk groups. The risk of ESRD in the moderate, high, and super-high-risk groups was significantly higher than that in the low-risk group. Herein, we are giving a detailed description of our grading system for IgA nephropathy that predicted the risk of dialysis based on the combination of CG and HG.</description><subject>Dialysis</subject><subject>Disease Progression</subject><subject>End-stage renal disease</subject><subject>Epidermal growth factor receptors</subject><subject>Excretion</subject><subject>Glomerular filtration rate</subject><subject>Glomerulonephritis, IGA - diagnosis</subject><subject>Glomerulonephritis, IGA - pathology</subject><subject>Glomerulonephritis, IGA - therapy</subject><subject>Hemodialysis</subject><subject>Humans</subject><subject>IgA nephropathy</subject><subject>Immunoglobulin A</subject><subject>Kidney diseases</subject><subject>Kidney Function Tests</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>Risk Assessment</subject><subject>Risk groups</subject><subject>Special Report</subject><subject>Urology</subject><issn>1342-1751</issn><issn>1437-7799</issn><issn>1437-7799</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kctu1TAQhiMEoqXwAGyQJTZsAp7Yjk82SEcVl0qV2MDacpw5iUtiB9uplHfpw-KcU8pFYmOPx9_8nvFfFC-BvgVK5bsIFIQsKexKqLfgUXEOnMlSyqZ5nGPGqxKkgLPiWYw3lNJdI5qnxRmjrJYM5Hlxtyd90J11PYlrTDiRNOhE5oCdNSnmE5Jg43fiD6SzelyjjcS6bjHJepcjctXvicN5CH7WaVhJXi26XNrqiB3J0KZh_NRap49FWeqYGq2zRo9Eu44MNiY_-v6YiHiLwab1efHkoMeIL-73i-Lbxw9fLz-X118-XV3ur0sjeJNK0-ZxuWFCIJW0rQGQcTAU5Y62kkotQDJKhaihaWWF2MmupgZZ_rwGecsuivcn3XlpJ-xMbj_oUc3BTjqsymur_r5xdlC9v1U145w1kAXe3AsE_2PBmNRko8Fx1A79ElUFVd1ALaHK6Ot_0Bu_BJfH2yghpODAMgUnygQfY8DDQzNA1ea9Onmvsvdq817RXPPqzykeKn6ZnYHqBMR85XoMv5_-v-pPHb28gg</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Okonogi, Hideo</creator><creator>Kawamura, Tetsuya</creator><creator>Joh, Kensuke</creator><creator>Koike, Kentaro</creator><creator>Miyazaki, Yoichi</creator><creator>Ogura, Makoto</creator><creator>Tsuboi, Nobuo</creator><creator>Hirano, Keita</creator><creator>Matsushima, Masato</creator><creator>Yokoo, Takashi</creator><creator>Horikoshi, Satoshi</creator><creator>Suzuki, Yusuke</creator><creator>Yasuda, Takashi</creator><creator>Shirai, Sayuri</creator><creator>Shibata, Takanori</creator><creator>Hattori, Motoshi</creator><creator>Akioka, Yuko</creator><creator>Katafuchi, Ritsuko</creator><creator>Hashiguchi, Akinori</creator><creator>Hisano, Satoshi</creator><creator>Shimizu, Akira</creator><creator>Kimura, Kenjiro</creator><creator>Maruyama, Shoichi</creator><creator>Matsuo, Seiichi</creator><creator>Tomino, Yasuhiko</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8376-5273</orcidid></search><sort><creationdate>20190101</creationdate><title>A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity</title><author>Okonogi, Hideo ; Kawamura, Tetsuya ; Joh, Kensuke ; Koike, Kentaro ; Miyazaki, Yoichi ; Ogura, Makoto ; Tsuboi, Nobuo ; Hirano, Keita ; Matsushima, Masato ; Yokoo, Takashi ; Horikoshi, Satoshi ; Suzuki, Yusuke ; Yasuda, Takashi ; Shirai, Sayuri ; Shibata, Takanori ; Hattori, Motoshi ; Akioka, Yuko ; Katafuchi, Ritsuko ; Hashiguchi, Akinori ; Hisano, Satoshi ; Shimizu, Akira ; Kimura, Kenjiro ; Maruyama, Shoichi ; Matsuo, Seiichi ; Tomino, Yasuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Dialysis</topic><topic>Disease Progression</topic><topic>End-stage renal disease</topic><topic>Epidermal growth factor receptors</topic><topic>Excretion</topic><topic>Glomerular filtration rate</topic><topic>Glomerulonephritis, IGA - diagnosis</topic><topic>Glomerulonephritis, IGA - pathology</topic><topic>Glomerulonephritis, IGA - therapy</topic><topic>Hemodialysis</topic><topic>Humans</topic><topic>IgA nephropathy</topic><topic>Immunoglobulin A</topic><topic>Kidney diseases</topic><topic>Kidney Function Tests</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>Risk Assessment</topic><topic>Risk groups</topic><topic>Special Report</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okonogi, Hideo</creatorcontrib><creatorcontrib>Kawamura, Tetsuya</creatorcontrib><creatorcontrib>Joh, Kensuke</creatorcontrib><creatorcontrib>Koike, Kentaro</creatorcontrib><creatorcontrib>Miyazaki, Yoichi</creatorcontrib><creatorcontrib>Ogura, Makoto</creatorcontrib><creatorcontrib>Tsuboi, Nobuo</creatorcontrib><creatorcontrib>Hirano, Keita</creatorcontrib><creatorcontrib>Matsushima, Masato</creatorcontrib><creatorcontrib>Yokoo, Takashi</creatorcontrib><creatorcontrib>Horikoshi, Satoshi</creatorcontrib><creatorcontrib>Suzuki, Yusuke</creatorcontrib><creatorcontrib>Yasuda, Takashi</creatorcontrib><creatorcontrib>Shirai, Sayuri</creatorcontrib><creatorcontrib>Shibata, Takanori</creatorcontrib><creatorcontrib>Hattori, Motoshi</creatorcontrib><creatorcontrib>Akioka, Yuko</creatorcontrib><creatorcontrib>Katafuchi, Ritsuko</creatorcontrib><creatorcontrib>Hashiguchi, Akinori</creatorcontrib><creatorcontrib>Hisano, Satoshi</creatorcontrib><creatorcontrib>Shimizu, Akira</creatorcontrib><creatorcontrib>Kimura, Kenjiro</creatorcontrib><creatorcontrib>Maruyama, Shoichi</creatorcontrib><creatorcontrib>Matsuo, Seiichi</creatorcontrib><creatorcontrib>Tomino, Yasuhiko</creatorcontrib><creatorcontrib>Special IgA Nephropathy Study Group</creatorcontrib><creatorcontrib>for The Special IgA Nephropathy Study Group</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okonogi, Hideo</au><au>Kawamura, Tetsuya</au><au>Joh, Kensuke</au><au>Koike, Kentaro</au><au>Miyazaki, Yoichi</au><au>Ogura, Makoto</au><au>Tsuboi, Nobuo</au><au>Hirano, Keita</au><au>Matsushima, Masato</au><au>Yokoo, Takashi</au><au>Horikoshi, Satoshi</au><au>Suzuki, Yusuke</au><au>Yasuda, Takashi</au><au>Shirai, Sayuri</au><au>Shibata, Takanori</au><au>Hattori, Motoshi</au><au>Akioka, Yuko</au><au>Katafuchi, Ritsuko</au><au>Hashiguchi, Akinori</au><au>Hisano, Satoshi</au><au>Shimizu, Akira</au><au>Kimura, Kenjiro</au><au>Maruyama, Shoichi</au><au>Matsuo, Seiichi</au><au>Tomino, Yasuhiko</au><aucorp>Special IgA Nephropathy Study Group</aucorp><aucorp>for The Special IgA Nephropathy Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity</atitle><jtitle>Clinical and experimental nephrology</jtitle><stitle>Clin Exp Nephrol</stitle><addtitle>Clin Exp Nephrol</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>23</volume><issue>1</issue><spage>16</spage><epage>25</epage><pages>16-25</pages><issn>1342-1751</issn><issn>1437-7799</issn><eissn>1437-7799</eissn><abstract>Histological classification is essential in the clinical management of immunoglobulin A nephropathy (IgAN). However, there are limitations in predicting the prognosis of IgAN based on histological information alone, which suggests the need for better prognostic models. Therefore, we defined a prognostic model by combining the grade of clinical severity with the histological grading system by the following processes. We included 270 patients and explored the clinical variables associated with progression to end-stage renal disease (ESRD). Then, we created a predictive clinical grading system and defined the risk grades for dialysis induction by a combination of the clinical grade (CG) and the histological grade (HG). A logistic regression analysis revealed that the 24-h urinary protein excretion (UPE) and the estimated glomerular filtration rate (eGFR) were significant independent variables. We selected UPE of 0.5 g/day and eGFR of 60 ml/min/1.73 m
2
as the threshold values for the classification of CG. The risk of progression to ESRD of patients with CG II and III was significantly higher than that of patients with CG I. The patients were then re-classified into nine compartments based on the combination of CG and HG. Furthermore, the nine compartments were grouped into four risk groups. The risk of ESRD in the moderate, high, and super-high-risk groups was significantly higher than that in the low-risk group. Herein, we are giving a detailed description of our grading system for IgA nephropathy that predicted the risk of dialysis based on the combination of CG and HG.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>30367317</pmid><doi>10.1007/s10157-018-1657-0</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-8376-5273</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1342-1751 |
ispartof | Clinical and experimental nephrology, 2019-01, Vol.23 (1), p.16-25 |
issn | 1342-1751 1437-7799 1437-7799 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6344391 |
source | Springer Nature |
subjects | Dialysis Disease Progression End-stage renal disease Epidermal growth factor receptors Excretion Glomerular filtration rate Glomerulonephritis, IGA - diagnosis Glomerulonephritis, IGA - pathology Glomerulonephritis, IGA - therapy Hemodialysis Humans IgA nephropathy Immunoglobulin A Kidney diseases Kidney Function Tests Medicine Medicine & Public Health Nephrology Risk Assessment Risk groups Special Report Urology |
title | A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A52%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20grading%20system%20that%20predicts%20the%20risk%20of%20dialysis%20induction%20in%20IgA%20nephropathy%20patients%20based%20on%20the%20combination%20of%20the%20clinical%20and%20histological%20severity&rft.jtitle=Clinical%20and%20experimental%20nephrology&rft.au=Okonogi,%20Hideo&rft.aucorp=Special%20IgA%20Nephropathy%20Study%20Group&rft.date=2019-01-01&rft.volume=23&rft.issue=1&rft.spage=16&rft.epage=25&rft.pages=16-25&rft.issn=1342-1751&rft.eissn=1437-7799&rft_id=info:doi/10.1007/s10157-018-1657-0&rft_dat=%3Cproquest_pubme%3E2125575413%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c549t-cb7994c355e070b611e341c0e780b707a51730055619b72eed7d60ce31579e4b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2125575413&rft_id=info:pmid/30367317&rfr_iscdi=true |